Immunoprecipitation of p130Cas and subsequent immunoblotting showed that FAK and PXN were both constitutively complexed with p130Cas in U87MG glioma cells, and that these complexes were not affected by imatinib or nilotinib treatment (Fig. S5). This evidence concerns the gene BCAR1 and central nervous system cancer.